David Epstein is the founder of Black Diamond Therapeutics. Black Diamond Therapeutics has raised $194M in total funding. Latest round: Series C.
David Epstein is the President and CEO of Black Diamond Therapeutics, a precision oncology medicine company focused on finding and developing small molecule, tumor-agnostic therapies. Under his leadership, the company has completed multiple financing rounds and is advancing its lead product candidates into clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library